Live Breaking News & Updates on Sergio Traversa

Stay updated with breaking news from Sergio traversa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Relmada Therapeutics (RLMD) Provides Corporate Update

Relmada Therapeutics (RLMD) Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cedric Ogorman , Sergio Traversa , Relmada Therapeutics Inc , Andrew Cutler As Senior Clinical Development Advisor , Relmada Therapeutics , Chief Executive , Chief Medical Officer , Senior Clinical Development Advisor ,

Relmada Therapeutics Provides Corporate Update

Company Well-Positioned for a Pivotal 2024 with Multiple Key Clinical Development Milestones Anticipated
Relmada s Strong Balance Sheet to Support the Company Through All of 2024 s Expected Critical. ....

Tim Mccarthy , Cedric Ogorman , Sergio Traversa , Prnewswire Relmada Therapeutics Inc , Corporate Communications , Securities Exchange , Key Clinical Development Milestones , Andrew Cutler As Senior Clinical Development Advisor , Relmada Therapeutics Inc , Company Well Positioned , Multiple Key Clinical Development Milestones , Strong Balance Sheet , Company Through All , Chief Executive , Chief Medical Officer , Cedrico Gorman , Andrew Cutler , Senior Clinical Development Advisor , Relmada Therapeutics , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act ,

Form 8-K RELMADA THERAPEUTICS, For: Jan 04

Form 8-K RELMADA THERAPEUTICS, For: Jan 04
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Sergio Traversa , Relmada Therapeutics Inc , Commission File Number , Securities Exchange , Exchange Act , Zip Code , General Instruction , Securities Act , Securities Exchange Act , Relmada Therapeutics , Current Report , Page Interactive Data File ,

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. And welcome to Relmada Therapeutics, Inc. Third Quarter 2023 Earnings Conference Call. At this time, all lines are in listen-only mode. ....

Marc Goodman , Maged Shenouda , Tim Mccarthy , Sergio Traversa , Charles Wang , Basma Radwan , Cedric Ogorman , Relmada Therapeutics Inc , Most Boycotted Companies , Relmada Therapeutics , Call Transcript November , Third Quarter , Chief Executive Officer , Chief Financial Officer , Cedrico Gorman , Chief Medical , Safe Harbor , Private Securities Litigation Reform , Boycotted Companies , Chief Medical Officer ,

Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results

Progress in Clinical Development and Financial Highlights ....

Sergio Traversa , Relmada Therapeutics Inc , Therapeutics Inc , Relight Phase , Clinical Development , Ash And Cash Equivalents ,